MENLO PARK, Calif., April 29, 2014 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB) and HistoGenetics, a global leader in Human Leukocyte Antigen (HLA) sequence-based typing (SBT), announced today…
MENLO PARK, Calif., April 2, 2014 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) will hold its quarterly conference call to discuss its First Quarter 2014 Financial Results on…
MENLO PARK, Calif., March 31, 2014 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II, today announced the release of a software upgrade for…
MENLO PARK, Calif., Feb. 10, 2014 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II DNA Sequencing System, announced that its Single Molecule, Real-Time…
MENLO PARK, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced financial results for the fourth quarter ended December 31, 2013. Total revenue for…
MENLO PARK, Calif., Jan. 10, 2014 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) will hold its quarterly conference call to discuss its Fourth Quarter and Year End 2013…
MENLO PARK, Calif., Dec. 3, 2013 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II DNA Sequencing System, today announced it is collaborating with…
MENLO PARK, Calif., Oct. 22, 2013 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced financial results for the third quarter ended September 30, 2013. Total revenue for…
MENLO PARK, Calif., Oct. 3, 2013 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) will hold its quarterly conference call to discuss its Third Quarter 2013 financial results on…
MENLO PARK, Calif., Oct. 3, 2013 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II DNA Sequencing System, today announced significant new product enhancements…
MENLO PARK, Calif., Sept. 25, 2013 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB), provider of the PacBio® RS II DNA Sequencing System, today announced that it has entered…
MENLO PARK, Calif., Aug. 1, 2013 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced financial results for the second quarter ended June 30, 2013. Revenue for the…
MENLO PARK, Calif., July 18, 2013 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II DNA Sequencing System, today announced that John F. Milligan,…
MENLO PARK, Calif., July 17, 2013 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) will hold its quarterly conference call to discuss Second Quarter 2013 financial results on Thursday, August…
PacBio® RS II With BluePippin™ Size Selection Platform Provides Customers Improved Ability to Sequence Longer DNA Fragments MENLO PARK, Calif. and BEVERLY, Mass., May 16, 2013 (GLOBE NEWSWIRE) — Pacific…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.